UNRESECTABLE SKIN SQUAMOUS CELL CARCINOMA
Clinical trials for UNRESECTABLE SKIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE SKIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE SKIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation-Immuno combo shows promise for tough skin cancers
Disease control Recruiting nowThis early-phase study tests the safety of combining targeted radiation (SBRT) with the immunotherapy drug atezolizumab for people with advanced skin squamous cell carcinoma that can or cannot be removed by surgery. The goal is to see if this combination can better control the ca…
Matched conditions: UNRESECTABLE SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
New hope for kidney transplant patients with advanced skin cancer: immune-boosting combo tested
Disease control Recruiting nowThis study tests whether combining two immunotherapy drugs (nivolumab and ipilimumab) with two anti-rejection medications (sirolimus and prednisone) can control advanced skin cancer in kidney transplant recipients without losing the transplanted kidney. About 16 adults with skin …
Matched conditions: UNRESECTABLE SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immune syst…
Matched conditions: UNRESECTABLE SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:04 UTC